The acquisition of Evofem Biosciences is a major strategic move for Aditxt, which could positively impact investor sentiment and the company's growth prospects. The high trading volume indicates strong investor interest, and the significant percentage of short interest, coupled with a small float, suggests a potential short squeeze, which could drive the price up in the short term. However, the long-term impact will depend on the successful integration of the acquisition and realization of synergies.